EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All Resources2024 US Conference – Sponsorship and Exhibitor Overview
Topic: Conference
Presentation
Free
Value-Based Healthcare
Topic: Health Care
Report
Members
GCSG 2024 US Conference Slides
Topic: Conference
Presentation
Members
